Cargando…
Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703722/ https://www.ncbi.nlm.nih.gov/pubmed/36443715 http://dx.doi.org/10.1186/s12885-022-10335-7 |
| _version_ | 1784839915432837120 |
|---|---|
| author | Martínez-Laperche, C. Sanz-Villanueva, L. Díaz Crespo, F. J. Muñiz, P. Martín Rojas, R. Carbonell, D. Chicano, M. Suárez-González, J. Menárguez, J. Kwon, M. Diez Martín, J. L. Buño, I. Bastos Oreiro, M. |
| author_facet | Martínez-Laperche, C. Sanz-Villanueva, L. Díaz Crespo, F. J. Muñiz, P. Martín Rojas, R. Carbonell, D. Chicano, M. Suárez-González, J. Menárguez, J. Kwon, M. Diez Martín, J. L. Buño, I. Bastos Oreiro, M. |
| author_sort | Martínez-Laperche, C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9703722 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97037222022-11-29 Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment Martínez-Laperche, C. Sanz-Villanueva, L. Díaz Crespo, F. J. Muñiz, P. Martín Rojas, R. Carbonell, D. Chicano, M. Suárez-González, J. Menárguez, J. Kwon, M. Diez Martín, J. L. Buño, I. Bastos Oreiro, M. BMC Cancer Correction BioMed Central 2022-11-28 /pmc/articles/PMC9703722/ /pubmed/36443715 http://dx.doi.org/10.1186/s12885-022-10335-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Martínez-Laperche, C. Sanz-Villanueva, L. Díaz Crespo, F. J. Muñiz, P. Martín Rojas, R. Carbonell, D. Chicano, M. Suárez-González, J. Menárguez, J. Kwon, M. Diez Martín, J. L. Buño, I. Bastos Oreiro, M. Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment |
| title | Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment |
| title_full | Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment |
| title_fullStr | Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment |
| title_full_unstemmed | Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment |
| title_short | Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment |
| title_sort | correction: ezh2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703722/ https://www.ncbi.nlm.nih.gov/pubmed/36443715 http://dx.doi.org/10.1186/s12885-022-10335-7 |
| work_keys_str_mv | AT martinezlaperchec correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT sanzvillanueval correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT diazcrespofj correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT munizp correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT martinrojasr correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT carbonelld correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT chicanom correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT suarezgonzalezj correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT menarguezj correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT kwonm correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT diezmartinjl correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT bunoi correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment AT bastosoreirom correctionezh2mutationsatdiagnosisinfollicularlymphomaapromisingbiomarkertoguidefrontlinetreatment |